SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006445
Filing Date
2018-08-06
Accepted
2018-08-06 16:06:38
Documents
115
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20180630x10q.htm 10-Q 2829175
2 EX-31.1 irwd-20180630ex311bb4d9d.htm EX-31.1 18544
3 EX-31.2 irwd-20180630ex312319dda.htm EX-31.2 18509
4 EX-32.1 irwd-20180630ex3216ea754.htm EX-32.1 8473
5 EX-32.2 irwd-20180630ex322f6f412.htm EX-32.2 8612
  Complete submission text file 0001558370-18-006445.txt   11914425

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20180630.xml EX-101.INS 2663521
7 EX-101.SCH irwd-20180630.xsd EX-101.SCH 89604
8 EX-101.CAL irwd-20180630_cal.xml EX-101.CAL 82055
9 EX-101.DEF irwd-20180630_def.xml EX-101.DEF 484806
10 EX-101.LAB irwd-20180630_lab.xml EX-101.LAB 725640
11 EX-101.PRE irwd-20180630_pre.xml EX-101.PRE 728236
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 18994770
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1